Ensocell

Curated by Signal

Developer of AI-based computational tools to discover therapeutics

Overview

Developer of AI-based computational tools to discover therapeutics. It utilises single cell RNA sequencing, AI-based computational tools, and advanced cell models to identify disease intervention points and to discover therapeutics for autoimmune, inflammatory, and fibrotic diseases.

Key facts

Founded: 2022
Headquarters: Cambridge, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

Open roles

1 role

AI Scientist
Hinxton, England, United Kingdom · On-site · Full-time

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Five to Nine
Provider of an app for one-minute animated video tip in the morning everyday for mindfulness practice
Health TechnologyUnited Kingdom
Second Nature
Provider of diet and nutrition planning app
Health TechnologyLondon, United Kingdom
AQUARATE
Provider of fluid intake monitoring devices for healthcare professionals
Health TechnologyLiverpool, United Kingdom

About Ensocell

What does Ensocell do?

Developer of AI-based computational tools to discover therapeutics.

Where is Ensocell headquartered?

Ensocell is headquartered in Cambridge, United Kingdom.

When was Ensocell founded?

Ensocell was founded in 2022.

Which sector is Ensocell in?

Ensocell operates in Health Technology.

Who are Ensocell's competitors?

Companies similar to Ensocell include Five to Nine, Second Nature, and AQUARATE.

Is Ensocell hiring?

Yes. Ensocell has 1 open role listed on Vanberra Signal.